Dr. Peter A. Campochiaro

Dr. Harry A. Quigley is the A. Edward Maumenee Professor of Ophthalmology and developed the Glaucoma Division at the Johns Hopkins Wilmer Eye Institute. He was a founding member of the American Glaucoma Society, serving for 8 years as its Secretary and was elected to 5 year terms as chief executive officer of the Association for Research in Vision and Ophthalmology (ARVO) and editor-in-chief of Investigative Ophthalmology and Visual Science. He has published over 350 peer-reviewed articles, and his reports are the most cited in the ophthalmic literature over the last 30 years (Archives of Ophthalmology, 2007). His research has improved the early diagnosis of glaucoma and has developed instruments and techniques to identify glaucoma damage better. He has participated in pioneering studies of the epidemiology, morbidity and progression rate of glaucoma and other eye disease in American, African, Asian and Hispanic populations, serving as a consultant to the World Health Organization. In the laboratory, he has demonstrated successful gene therapy to protect retinal ganglion cells from experimental glaucoma and developed glaucoma models in monkeys, rats and mice. Dr. Quigley is rated as a Distinguished provider by MediFind in Trabeculectomy. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Pigment-Dispersion Syndrome, Trabeculectomy, and Iridectomy.

Nathan Congdon is an Ophthalmologist in Baltimore, Maryland. Dr. Congdon is rated as a Distinguished provider by MediFind in Trabeculectomy. His top areas of expertise are Presbyopia, Nearsightedness, Diabetic Retinopathy, Cataract Removal, and Trabeculectomy.

Henry D. Jampel, M.D., M.H.S., is the Odd Fellows Professor of Ophthalmology at the Wilmer Eye Institute. He specializes in glaucoma and serves as the medical director of Wilmer's Green Spring Station location. His research interests include evaluation of medical vs. surgical treatment of glaucoma in newly diagnosed patients and on imaging devices for the detection of glaucoma and its progression. Dr. Jampel received his M.D. degree from Yale University and his M.H.S. in health finance and management from the Johns Hopkins Bloomberg School of Public Health. He completed an internship in internal medicine at Sinai Hospital and his residency in ophthalmology at the Wilmer Eye Institute. After completing a glaucoma fellowship in glaucoma at Wilmer, Dr. Jampel joined the faculty in 1988. Dr. Jampel is rated as a Distinguished provider by MediFind in Trabeculectomy. His top areas of expertise are Glaucoma, Ocular Hypertension (OHT), Sturge-Weber Syndrome, Trabeculectomy, and Cataract Removal.